Jiangsu Sihuan Bioengineering Co., Ltd

000518

CNE0000001P8

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 18:00:00 2024-05-16 EDT			5-day change	1st Jan Change
2.45 ^CNY	0.00%		-12.50%	-26.20%

04-29	Jiangsu Sihuan Bioengineering Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
2023	Jiangsu Sihuan Bioengineering Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	CI

Jiangsu Sihuan Bioengineering Co., Ltd Announces Directors Appointments

June 27, 2023 at 03:33 pm

Jiangsu Sihuan Bioengineering Co. Ltd. held its 1st Extraordinary General Meeting of 2023 on 26 June 2023 were approved election of Lu Yu as non-independent directors, Wu Liangwei and Wang Li as independent directors.

Latest news about Jiangsu Sihuan Bioengineering Co., Ltd

Jiangsu Sihuan Bioengineering Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	04-29	CI
Jiangsu Sihuan Bioengineering Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Jiangsu Sihuan Bioengineering Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-22	CI
Jiangsu Sihuan Bioengineering Co., Ltd Announces Directors Appointments	23-06-27	CI
Jiangsu Sihuan Bioengineering Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Jiangsu Sihuan Bioengineering Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-26	CI
Jiangsu Sihuan Bioengineering Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-25	CI
Jiangsu Sihuan Bioengineering Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-19	CI
Jiangsu Sihuan Bioengineering Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-28	CI
Jiangsu Sihuan Bioengineering Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-27	CI
Jiangsu Sihuan Bioengineering Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-28	CI
Jiangsu Sihuan Bioengineering Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-27	CI
Guangxi Ainong Investment Co., Ltd. and Wang Shaofeng signed an agreement to acquire Guangxi Intercontinental Forestry Investment Co., Ltd. from Jiangsu Sihuan Bioengineering Co., Ltd for CNY 37.8 million.	21-04-23	CI
Jiangsu Sihuan Bioengineering Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-14	CI
Jiangsu Sihuan Bioengineering Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-29	CI
Jiangsu Sihuan Bioengineering Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-28	CI
Jiangsu Sihuan Bioengineering Co., Ltd Approves Board Appointments	20-06-22	CI
Jiangsu Sihuan Bioengineering Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2020	20-04-27	CI
Jiangsu Sihuan Bioengineering Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2019	20-04-15	CI
Jiangsu Sihuan Bioengineering Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2019	19-10-30	CI
Jiangsu Sihuan Bioengineering Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2019	19-08-30	CI
Jiangsu Sihuan Bioengineering Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2019	19-04-29	CI
Jiangsu Sihuan Bioengineering Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2018	19-04-15	CI
Jiangsu Sihuan Bioengineering Co., Ltd(SZSE:000518) dropped from Shenzhen Stock Exchange Component Index	18-01-01	CI
Jiangsu Sihuan Bioengineering Co., Ltd(SZSE:000518) dropped from Shenzhen Stock Exchange Component A Share Index	18-01-01	CI

Chart Jiangsu Sihuan Bioengineering Co., Ltd

Duration

Period

Chart Jiangsu Sihuan Bioengineering Co., Ltd

More charts

Company Profile

JIANGSU SIHUAN BIOENGINEERING CO., LTD is a China-based company principally engaged in the research, development, manufacture and distribution of medicines and health supplements. The Companyâs main products include interleukin, erythropoietin (EPO), granulocyte colony-stimulating factor (G-CSF), tablets, bulk drugs, infusion glass bottles, soft bag infusion, syrup and healthcare products, among others. The Company is also engaged in landscape engineering, maintenance projects, the sale of nursery stocks and other businesses. The Company distributes its products in domestic market and to overseas markets.

Sector

Pharmaceuticals

Calendar

2024-05-21 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Biopharmaceuticals

	1st Jan change	Capi.
JIANGSU SIHUAN BIOENGINEERING CO., LTD	-26.20%	349M
CSL LIMITED	-2.32%	90.45B
SAMSUNG BIOLOGICS CO.,LTD.	+3.68%	41.45B
BIOGEN INC.	-10.90%	33.57B
UCB	+58.05%	25.73B
BIOMARIN PHARMACEUTICAL INC.	-19.56%	14.73B
INCYTE CORPORATION	-9.06%	12.82B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-11.34%	11.7B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-43.53%	11.44B
SWEDISH ORPHAN BIOVITRUM AB	+3.75%	8.79B

Biopharmaceuticals